The global Biosimilars Market Size is on a high-growth trajectory, with a market value of USD 29.51 billion in 2023, projected to reach an impressive USD 127.92 billion by 2032. This substantial expansion represents a compound annual growth rate (CAGR) of 17.7% over the forecast period from 2024 to 2032, according to a newly released industry report. Biosimilars are biologic medical products...